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This paper examines the effect of neighborhood disadvantage on racial disparities in ovarian
cancer-specific survival. Despite treatment advances for ovarian cancer, survival remains
shorter for African-American compared to White women. Neighborhood disadvantage is
implicated in racial disparities across a variety of health outcomes and may contribute to
racial disparities in ovarian cancer-specific survival. Data were obtained from 581 women
(100 African-American and 481 White) diagnosed with epithelial ovarian cancer between
June 1, 1994, and December 31, 1998 in Cook County, IL, USA, which includes the city of
Chicago. Neighborhood disadvantage score at the time of diagnosis was calculated for each
woman based on Browning and Cagney’s index of concentrated disadvantage. Cox pro-
portional hazard models measured the association of self-identified African-American race
with ovarian cancer-specific survival after adjusting for age, tumor characteristics, surgical
debulking, and neighborhood disadvantage. There was a statistically significant negative
association (−0.645) between ovarian cancer-specific survival and neighborhood disad-
vantage (p=0.008). After adjusting for age and tumor characteristics, African-American
women were more likely than Whites to die of ovarian cancer (HR=1.59, p=0.003). After
accounting for neighborhood disadvantage, this risk was attenuated (HR=1.32, p=0.10).
These findings demonstrate that neighborhood disadvantage is associated with ovarian
cancer-specific survival and may contribute to the racial disparity in survival.
Keywords: ovarian cancer and socioeconomic status, survival analysis, healthcare disparities, neighborhood effect,
racial disparities in ovarian cancer
INTRODUCTION
Ovarian cancer is the fifth leading cause of cancer death among
U.S. women, with an estimated 21,980 new cases diagnosed in
2014 and 14,270 deaths (1). Across study populations, the inci-
dence of ovarian cancer has been consistently higher in White
women than in African-American women (2–4). Paradoxically,
African-Americans have been consistently found to have poorer
survival than Whites at all stages of this disease (5–7). Recent SEER
data show improvements in the 5-year relative survival for women
diagnosed with ovarian cancer, yet these rates remain significantly
lower for African-American women compared to Whites (36 and
44%, respectively) (1).
Racial disparities in cancer survival are typically assessed solely
in terms of individual-level factors, and rightly so. Racial differ-
ences in individual-level demographic and clinical factors play
an important role in prolonging or shortening survival following
diagnosis of various types of cancer (8–10). Yet, these individual-
level differences may be due in part to differences in neighborhood
environments, and excluding this important contextual factor may
produce an incomplete picture. This analysis explores the role
that neighborhood, and in particular neighborhood disadvantage,
plays in explaining the racial disparity in ovarian cancer survival.
Sampson and colleagues (11, 12) have defined neighborhoods
as “ecological units nested within successively larger communi-
ties.” Implicit in this definition is the concept of neighborhood
differentiation, which includes aspects such as social inequality
between neighborhoods and the idea that neighborhood char-
acteristics can influence aspects of residents’ lives. One aspect
of social inequality at the neighborhood level is residential
segregation. Massey and Denton (13) describe the damaging
social consequences of residential segregation, which include
social and economic isolation as well as structural environments
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characterized by physical decay, crime, and social disorder. Ellen
and colleagues (14) propose several pathways by which neigh-
borhoods can affect health. For example, weak neighborhood
resources can reduce access to and quality of healthcare, and
physical stresses in a neighborhood can pose challenges to
health-promoting behaviors such as physical activity and healthy
eating.
Neighborhood disadvantage has been implicated in racial dis-
parities across a variety of health outcomes (15–17) above and
beyond individual-level demographic, socioeconomic, and clin-
ical factors (18–20), and differences in neighborhood disadvan-
tage may also contribute to disparities in ovarian cancer-specific
survival. Sampson and colleagues (12) suggest several ways in
which the effect of neighborhood disadvantage may be particu-
larly strong for African-Americans. These include the connection
between concentrated disadvantage and residential isolation, as
well as the “bundling” of social problems that occur at the neigh-
borhood level, such as weak bonds of social support, economic
uncertainty, and both social and physical disorder. Residence in
high-poverty neighborhoods has been associated with shorter sur-
vival in individuals diagnosed with breast cancer (21, 22), prostate
cancer (23), and lung cancer (24), and this may also be the case for
women with ovarian cancer.
Using Browning and Cagney’s (25) index of concentrated dis-
advantage, we examined whether neighborhood disadvantage was
associated with cancer-specific survival, and whether this associ-
ation helped to explain any observed survival disparity among
African-American and White women diagnosed with ovarian
cancer in Cook County, IL, USA, which includes the city of
Chicago.
MATERIALS AND METHODS
STUDY POPULATION
Cases from an original case–control study examining the etiology
of ovarian cancer were recruited from hospitals in Cook County,
IL, USA between June 1, 1994, and December 31, 1998. Eighty-
three percent of hospitals in Cook County participated in the
study. These hospitals represent a wide array of community hos-
pitals in the Chicago metropolitan area, including major teaching
hospitals, county hospitals, and system affiliated hospitals in a
range of sizes. Identified cases were subsequently sent to the Illinois
State Cancer Registry (ISCR) to determine whether any eligible
cases had been missed. Of the 1,562 identified by ISCR during
the ascertainment period, 1,210 (77.5%) were part of the original
case–control study. The remaining 352 ISCR cases were excluded
for the following reasons: cases could not be reviewed for eligibil-
ity because they were diagnosed in a non-participating hospital
(n= 130), the medical record could not be obtained (n= 75),
the case was identified through death certificate (n= 35), and
the case did not meet the study’s age or race eligibility criteria
(n= 112). Diagnosis was confirmed after surgical biopsy using
the International Histological Classification of Ovarian Tumors
recommended by the Féderation Internationàle de Gynécolo-
gie et d’Obstétrique (FIGO) (26). A pathology review of 386 of
the eligible cases was conducted by an independent gynecologic
pathologist. Hospital pathology reports were used for histologic
classification for the remaining cases.
Cases of epithelial ovarian cancer (“ovarian cancer”) were
eligible for inclusion in this analysis if they were residents of Cook
County, treated at one of the participating hospitals, 18–74 years
old at the time of diagnosis, and self-reported their race as either
“Black” or “White.” Among the 1,210 cases available between June
1, 1994 and December 31, 1998, 702 met the eligibility criteria.
After reviewing histology codes, 102 tumors were determined to
be either benign, stromal, or of germ-cell origin, and were subse-
quently excluded from this analysis. Of the remaining 600 cases,
vital status was valid for 581 women. The protocol was approved
by the University of Illinois at Chicago Institutional Review Board.
VITAL STATUS
Case information was submitted to the National Death Index
(NDI) and matched through December 2008. Vital status was
determined through a manual review of the NDI Summary file,
with dates of death recorded for all linked cases. In cases with more
than one possible match, the record with the most data items in
agreement was used. Unlinked cases were right-censored at the
last date of December 31, 2008. The cause of death was classified
as either ovarian cancer or ovarian cancer-related death using the
underlying and selected-cause codes from the appropriate revision
of the International Classification of Diseases (ICD-9, -10). The
study endpoint was ovarian cancer-specific survival time calcu-
lated by subtracting the date of ovarian cancer diagnosis from the
date of death due to ovarian cancer or censoring at the last date of
December 31, 2008.
VARIABLES
A composite variable representing neighborhood disadvantage
was constructed using U.S. Census data and was based on Brown-
ing and Cagney’s concentrated disadvantage factor, which was
dominated by high factor loadings for percent below the poverty
line, unemployed, in female-headed households, under age 18, and
African-American (25). Because the case-ascertainment period
(i.e., 1994–1998) spanned two U.S. Census periods, both the 1990
and 2000 census periods were used to develop the variable. Each
patient’s residential address at the time of diagnosis was geocoded
to the block level and then located within a census tract. Data
from the 1990 and 2000 Census periods were used to create inter-
polated values representing the midpoint in the ascertainment
period (i.e., 1996) for each of the following census variables: per-
cent below poverty, percent unemployed, percent receiving public
assistance, percent in female-headed households, percent under
age 18, and percent African-American. Each interpolated value
was standardized (i.e., converted to z-scores). The variables were
then summed with equal weighting and standardized to create
the final disadvantage index variable. Higher scores represented
greater concentrated disadvantage.
Stage at diagnosis was analyzed as late-stage (FIGO III/IV)
versus early-stage (FIGO I/II) diagnosis. The pathologic grade
of tumors was classified as high pathologic grade (moderately
to poorly differentiated) versus low grade (well differentiated).
The FIGO version of the World Health Organization’s histologic
typology of ovarian tumors was used to classify the six categories
of epithelial tumors: serous, mucinous, clear cell, endometri-
oid, undifferentiated, and unclassified. (Tumors were considered
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unclassified if they could not be assigned to any of the other five
groups or if they had no histology.) Epithelial histologic sub-type
was analyzed as serous versus all others due to small cell sizes in
the non-serous sub-types. Finally, tumors were considered sub-
optimally debulked following initial surgery when residual lesions
were>2 cm (the definition at the time cases were diagnosed), and
considered optimally debulked when lesions were 2 cm or less.
Only epithelial tumors were included in this analysis.
STATISTICAL ANALYSIS
Differences in the distribution of tumor characteristics by race
and quartile of disadvantage were tested using Chi-square and
t -test statistics for categorical and continuous variables, respec-
tively. Simple linear regression was used to evaluate the associa-
tion between cancer-specific survival time and disadvantage. The
Cochran–Armitage test was used to evaluate the linear trend of
variables by quartile of disadvantage. Unadjusted Kaplan–Meier
5- and 10-year survival rates and 95% confidence intervals were
estimated for African-American and White women.
Three Cox proportional hazard (PH) models measured the
association of race (African-American) with ovarian cancer-
specific survival time: Model 1 estimated the age-adjusted hazard
of death by race; Model 2 estimated the hazard of death by race
controlling for age, tumor characteristics, and surgical debulking;
Model 3 estimated the hazard of death by race controlling for
age, tumor characteristics, surgical debulking, and neighborhood
disadvantage (comparing the highest quartile of disadvantage to
the lower three quartiles as the reference category). Product terms
tested the interaction between race and disadvantage. No viola-
tions of the PHs assumption were observed (p values for inter-
action with time ranged from 0.45 to 0.88). Similar Cox models
were run with the shared frailty model to account for clustered
data (i.e., cases within census tracts.) Analyses were performed
using SAS (v9.3, Cary, NC, USA).
RESULTS
By the end of the follow-up period, 87 of 100 (87%) African-
Americans versus 358 of 481 (74%) Whites had died (p= 0.007).
The mean survival time for African-Americans was 16.9 months
shorter than for Whites (61.5 versus 78.4 months, p= 0.007).
There was a statistically significant negative association (−0.645)
between ovarian cancer-specific survival and neighborhood dis-
advantage (p= 0.008) (Results not shown).
Table 1 presents the distribution and association of patient
characteristics by race and quartile of disadvantage. Median sur-
vival was 3.18 years for African-Americans versus 5.31 years for
Table 1 | Percent distribution and association of patient characteristics, by race and quartilea of disadvantage (n=581).
Race By quartile of disadvantage score
African-Americans Whites p 1st 2nd 3rd 4th p Trend
n=100 (%) n=481(%) n=146 (%) n=145 (%) n=145 (%) n=145 (%)
Mean survival in years 5.12 6.54 0.007 6.55 6.82 6.45 5.35 0.46
(SD) (−0.45) (−0.2) (−4.8) (−4.8) (−4.7) (−4.7)
[Median] [3.18] [5.31] [5.27] [5.61] [5.30] [2.99]
FIGO stage at diagnosis
Early (FIGO I/II) 42 (42) 224 (46.6) 0.40 75 (51.4) 64 (44.1) 69 (47.6) 58 (40) 0.09
Late (FIGO III/IV) 58 (58) 257 (53.4) 71 (48.6) 81 (55.9) 76 (52.4) 87 (60)
Pathologic grade
Low-grade 26 (26) 150 (31.2) 0.30 48 (32.9) 49 (33.8) 48 (33.1) 31 (21.4) 0.04
High-grade 74 (74) 331 (68.8) 98 (67.1) 96 (66.2) 97 (66.9) 114 (78.6)
Histologic sub-type
Serous 53 (53) 230 (47.8) 0.35 67 (45.9) 71 (49) 73 (50.3) 72 (49.7) 0.49
All others 47 (47) 251 (52.2) 79 (54.1) 74 (51) 72 (49.7) 73 (50.3)
Surgical debulking (missing=25)
Optimal debulking 45 (51.7) 278 (59.3) 0.19 92 (63.9) 82 (59) 82 (58.2) 67 (50.8) 0.03
Suboptimal debulking 42 (48.3) 191 (40.7) 52 (36.1) 57 (41) 59 (41.8) 65 (49.2)
Mean disadvantage scoreb 0.79 −0.65 <0.0001
(SD) (0.84) (0.34)
[Range] [−0.93, 2.33] [−1.06, 1.71]
Quartile of disadvantage
Highest (4th Q) 85 (85) 60 (12) <0.0001
1st–3rd Quartiles 15 (15) 421 (88)
aNeighborhood disadvantage divided into fourths at the quartiles of the sample distribution.
bHigher scores reflect greater concentrated disadvantage.
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Whites (p= 0.007). There were no statistically significant differ-
ences in tumor characteristics between the two groups of women.
African-American women in the study lived in neighborhoods
with significantly higher mean disadvantage scores compared to
White women (0.79 versus−0.65, p< 0.0001), and the majority of
African-Americans lived in neighborhoods in the highest quartile
of disadvantage (85%), compared to 12% of Whites (p< 0.0001).
The highest quartile of neighborhood disadvantage was
associated with late-stage diagnosis (p= 0.05), high-grade
tumors (p= 0.03), suboptimal debulking (p= 0.03), and race
(p< 0.0001). The likelihood of being diagnosed with higher grade
tumors and receiving suboptimal debulking was also associated
with increasing quartile of disadvantage, and was marginally asso-
ciated with late-stage diagnosis (p= 0.04, p= 0.03, and p= 0.09,
respectively). Because the strongest effect of disadvantage was
observed in the highest quartile, this variable was evaluated as
a binary variable in the subsequent series of Cox models.
Table 2 | Kaplan–Meier ovarian cancer-specific survival rates (95% CI),
by race (n=581).
Survival rate (95% CI)
5-year 10-year
African-Americans 0.41 (0.31, 0.51) 0.24 (0.16, 0.33)
Whites 0.62 (0.57, 0.66) 0.43 (0.39, 0.48)
The unadjusted Kaplan–Meier 5-year cancer-specific survival
rates for African-Americans and Whites were 41 and 62%,
respectively, and 24 and 43%, respectively, for 10-year survival
(Table 2).
The results of age-adjusted Cox PH models estimating the
association between race (African-American) and ovarian cancer-
specific mortality are presented in Table 3. African-American
women were more likely than White women to die of ovarian
cancer (Model 1: HR= 1.54, p= 0.004). This increased risk held
after adjusting for tumor characteristics (Model 2: HR= 1.59,
p= 0.003). However, after accounting for neighborhood disad-
vantage, this risk was attenuated (Model 3: HR= 1.32, p= 0.10).
There was no statistically significant interaction between race and
disadvantage, and a model accounting for clustered data produced
nearly identical results to the Table 3 model ignoring clustering
(data not shown).
DISCUSSION
Our findings are consistent with similar analyses examining the
effect of neighborhood environment on survival in residents with
breast (27), prostate (23), and lung cancer (24). To our knowledge
there are no published reports examining the effect of neighbor-
hood disadvantage (or neighborhood-level socioeconomic status)
on racial disparities in ovarian cancer-specific survival. However,
at the individual-level, lower socioeconomic status has been asso-
ciated with poorer survival in women diagnosed with invasive
ovarian cancer (28–30).
Table 3 | Hazard ratios (HR) for African-American versus White ovarian cancer-specific mortality.
Variables Model 1a Model 2b Model 3c
HR (95% CI) p HR (95% CI) p HR (95% CI) p
Race
White 1.00 (reference) 0.004 1.00 (reference) 0.003 1.00 (reference) 0.10
African-American 1.54 (1.21, 1.94) 1.59 (1.23, 2.04) 1.32 (0.95, 1.84)
Stage at diagnosis
Early (FIGO I/II) 1.00 (reference) 0.0012 1.00 (reference) 0.0016
Late (FIGO III/IV) 1.72 (1.24, 2.39) 1.70 (1.22, 2.36)
Pathologic grade
Low-grade 1.00 (reference) 0.47 1.00 (reference) 0.54
High-grade 1.09 (0.86, 1.39) 1.08 (0.85, 1.37)
Histologic sub-type
All others 1.00 (reference) 0.48 1.00 (reference) 0.51
Serous 1.08 (0.87, 1.33) 1.07 (0.87, 1.32)
Surgical debulking (missing=25)
Optimal debulking 1.00 (reference) <0.0001 1.00 (reference) <0.0001
Suboptimal debulking 2.08 (1.52, 2.83) 2.12 (1.55, 2.90)
Disadvantage
1st–3rd Quartiles combined 1.00 (reference) 0.09
4th Quartile (highest) 1.28 (0.96, 1.70)
aAdjusted for age at diagnosis.
bAdjusted for age, stage at diagnosis, pathologic grade, histologic sub-type, and surgical debulking.
cAdjusted for age, stage at diagnosis, pathologic grade, histologic sub-type, surgical debulking, and concentrated disadvantage.
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This study shows that neighborhood disadvantage is associ-
ated with ovarian cancer-specific survival and may contribute
to the racial disparity in such survival. Although the pathways
through which neighborhood disadvantage influences survival
are challenging to measure, we hypothesize several causal rela-
tions between indicators of neighborhood disadvantage and ovar-
ian cancer-specific survival. Neighborhood disadvantage adversely
affects both individual- and neighborhood-level socioeconomic
status, as well as the physical and structural environment of
the community (31). At the individual level, poverty may affect
survival through higher rates of comorbidities (32), which may
influence both physicians’ recommendations and women’s abili-
ties to receive and complete treatment for advanced ovarian cancer
(33, 34). Poverty and unemployment are associated with inad-
equate health insurance (32, 35), which impacts the quality of
available healthcare (36–40) in terms of treatment (41) as well as
management of treatment and disease complications (42).
In addition, neighborhood socioeconomic status is an impor-
tant contextual factor that negatively impacts health outcomes
beyond an individual’s own circumstances (43, 44). An environ-
ment of high poverty, high unemployment, and low educational
attainment can produce conditions in which priorities such as
personal safety, maintaining employment, and caring for one’s
family take precedence over health (45–47). These competing pri-
orities can result in later-stage diagnosis and can make treatment
completion difficult (48, 49).
Finally, neighborhoods of high concentrated disadvantage
expose residents to environmental stressors including crime,
neighborhood disorder and decay, and discrimination (50, 51).
These environmental stressors may place residents at risk for
high levels of stress and distress (52, 53), both of which have an
adverse effect on immune processes involved in cancer progres-
sion (54) and may increase the likelihood of advanced ovarian
cancer (55, 56). For all of these reasons, living in a neighborhood
with increased concentrated disadvantage adds an “additional
layer of vulnerability” over and above an individual’s personal
circumstances (57).
Although this study provides useful insights into the pos-
sible causes of racial disparity in ovarian cancer-specific sur-
vival between African-American and White women, we acknowl-
edge important limitations which should be addressed in future
research. First, direct measures of healthcare access and uti-
lization were not included in this study, and they should be
examined in order to assess their possible contribution to dis-
parate survival. Second, the length of residency within a census
tract was not known, so models could not account for poten-
tial changes in residency after diagnosis. Third, the impacts
of prescribed treatment and patients’ responses to that treat-
ment on the survival disparity were not measured. Research
has shown that African-Americans are less likely to receive the
type of optimal treatment associated with longer survival (29,
58, 59). It is possible that the African-American women in our
study may have received less optimal treatment than Whites in
terms of cytoreductive surgery or chemotherapeutic regimen,
or both, possibly due to differences in healthcare providers or
comorbidities that prevented the use of certain therapies (60).
Finally, cases were among women diagnosed with ovarian cancer
exclusively in Cook County, IL, USA and from a subset of hospitals
within the county, which may not be representative of the gen-
eral population of ovarian cancer patients in the U.S., partic-
ularly with respect to stage at diagnosis or receipt of surgical
treatment.
This analysis demonstrates that neighborhood disadvantage
is an independent predictor of ovarian cancer-specific survival
and may contribute to the racial disparity in survival. This asso-
ciation is most evident in the highest quartile of concentrated
disadvantage, suggesting a gradient effect (61) of neighborhood
disadvantage on racially disparate survival. Future studies of the
racial disparity in ovarian cancer-specific survival should also
examine the role of neighborhood disadvantage, accounting for
racial differences in treatment.
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